Versant Capital Management
AGIO icon

Versant Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Versant Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66.5K Hold
2,001
– – 0.01% 1207
2026
Q2 		$74.3K Buy
2,001
+1,583
+379% +$48K 0.01% 1097
2026
Q1 		$14.1K Buy
418
+326
+354% +$9.24K ﹤0.01% 1981
2025
Q4 		$2.5K Sell
92
-224
-71% -$7.86K ﹤0.01% 2410
2025
Q3 		$12.7K Hold
316
– – ﹤0.01% 1828
2025
Q2 		$10.5K Buy
+316
New +$9.6K ﹤0.01% 1868
2023
Q3 		– Sell
-64
Closed -$1.81K – 1938
2023
Q2 		$1.81K Buy
+64
New +$1.59K ﹤0.01% 1410

Other funds holding AGIO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Versant Capital Management's AGIO Position: Q3 2026 in Review

Versant Capital Management held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 2,001 shares worth $66.5K. The position accounts for 0.01% of the portfolio, ranked #1207.

Versant Capital Management first reported a position in AGIO in Q2 2023 and has held it in 7 quarters since. The position peaked at $74.3K in Q2 2026. 175 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Versant Capital Management held 2,001 shares of Agios Pharmaceuticals worth $66.5K as of Q3 2026.
  • Versant Capital Management left its Agios Pharmaceuticals share count unchanged in Q3 2026.
  • Agios Pharmaceuticals made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #1207 holding.
  • Versant Capital Management first reported a position in Agios Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • Versant Capital Management's Agios Pharmaceuticals position peaked at $74.3K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.